Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Droller

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Urologic Oncology|February 6, 2013
New steps forward for Urologic OncologyMichael J Droller
Urologic Oncology|February 22, 2025
Thank YouMichael J Droller
The Journal of Urology|April 17, 2002
Chemoradiotherapy for muscle invading bladder carcinoma. Final report of a single institutional organ-sparing programMichael J Droller
Urologic Oncology|December 22, 2023
Editors in transitionMichael J Droller
Urologic Oncology|January 11, 2015
An editor's considerations in publishing industry-sponsored studiesMichael J Droller
The Journal of Urology|October 22, 2008
Peer review of guidelines, best practice statements and new documents: what this means for how we use themMichael J Droller
The Journal of Urology|March 3, 2009
A guideline for discussion and some thoughtsMichael J Droller
Urologic Oncology|March 29, 2021
Introduction to the 25th anniversary issueMichael J Droller
The Journal of Urology|July 26, 2002
Evaluation of cellular tumour rejection mechanisms in the peritumoral bladder wall after bacillus Calmette-Guérin treatmentMichael J Droller
The Journal of Urology|July 26, 2002
Risk of continued intravesical therapy and delayed cystectomy in the BCG-refractory superficial bladder cancer: an investigational approachMichael J Droller
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Urologic Oncology|February 6, 2013
New steps forward for Urologic OncologyMichael J Droller
Urologic Oncology|February 22, 2025
Thank YouMichael J Droller
The Journal of Urology|April 17, 2002
Chemoradiotherapy for muscle invading bladder carcinoma. Final report of a single institutional organ-sparing programMichael J Droller
Urologic Oncology|December 22, 2023
Editors in transitionMichael J Droller
Urologic Oncology|January 11, 2015
An editor's considerations in publishing industry-sponsored studiesMichael J Droller
The Journal of Urology|October 22, 2008
Peer review of guidelines, best practice statements and new documents: what this means for how we use themMichael J Droller
The Journal of Urology|March 3, 2009
A guideline for discussion and some thoughtsMichael J Droller
Urologic Oncology|March 29, 2021
Introduction to the 25th anniversary issueMichael J Droller
The Journal of Urology|July 26, 2002
Evaluation of cellular tumour rejection mechanisms in the peritumoral bladder wall after bacillus Calmette-Guérin treatmentMichael J Droller
The Journal of Urology|July 26, 2002
Risk of continued intravesical therapy and delayed cystectomy in the BCG-refractory superficial bladder cancer: an investigational approachMichael J Droller
Pageof 8